- Home
- TFSL vs KNSA Comparison
TFSL vs KNSA Comparison
Compare TFSL & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TFSL | KNSA |
|---|---|---|
| Founded | 1938 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.5B |
| IPO Year | 2006 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TFSL | KNSA |
|---|---|---|
| Price | $15.87 | $48.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $60.86 |
| AVG Volume (30 Days) | ★ 878.6K | 501.4K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | ★ 7.68% | N/A |
| EPS Growth | 14.29 | ★ 225.00 |
| EPS | 0.16 | ★ 0.27 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $9.16 | $37.48 |
| Revenue Next Year | $5.22 | $17.87 |
| P/E Ratio | ★ $98.72 | $188.52 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $12.54 | $26.27 |
| 52 Week High | $16.20 | $59.87 |
Technical Indicators
Market Signals| Indicator | TFSL | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 67.90 | 36.64 |
| Support Level | $13.16 | $40.67 |
| Resistance Level | N/A | $49.57 |
| Average True Range (ATR) | 0.33 | 2.02 |
| MACD | 0.03 | -1.15 |
| Stochastic Oscillator | 80.75 | 3.18 |
Price Performance
Historical ComparisonAbout TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.